Downregulation of CCN3 expression as a potential mechanism for melanoma progression.

Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Abstract Text:

Coculture of human melanocytes with keratinocytes upregulates CCN3, a matricellular protein critical to maintenance of normal homeostasis of melanocytes in the skin. CCN3 affects two fundamental features of melanocyte physiology: it inhibits melanocyte proliferation and stimulates their adhesion to the basement membrane. Here we report that expression of CCN3 is downregulated in advanced melanomas. Aggressive melanoma cell lines did not respond to treatment with CCN3 inducers, such as interleukin-1beta (IL-1beta), while less aggressive melanoma cell lines responded similarly to melanocytes. Immunostaining analyses revealed that CCN3 was present in melanoma cells close to the epidermal-dermal interface, but not in melanoma cells that had invaded deep into the dermis or had metastasized to lymph nodes. Contrary to our expectations, overexpression of CCN3 in 1205Lu metastatic melanoma cells did not affect their adhesion to collagen IV. However, CCN3 decreased the transcription and activation of matrix metalloproteinases and suppressed the invasion of 1205Lu melanoma cells. These results suggest that the lack of CCN3 in advanced melanoma cells contributes to their invasive phenotype. Whereas major matricellular proteins, such as osteopontin, tenascin or secreted protein acidic and rich in cysteine (SPARC), are strongly upregulated in melanoma cells; CCN3 is the first member of this family that is downregulated.

Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Oncogene

VOLUME: 27

Page Numbers: 2552-60

Journal Abbreviation: Oncogene

ISSN: 1476-5594

DAY: 29

MONTH: 10

YEAR: 2007

Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8711562

Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Downregulation of CCN3 expression as a potential mechanism for melanoma progression.

AFFILIATION: Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA 19104, USA.

Country: England

AGENCY: United States NCI

GRANT: CA80999

ACRONYM: CA

MEDLINETA: Oncogene

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Downregulation of CCN3 expression as a potential mechanism for melanoma progression Related Publications

• Adenovirus infection enhances killing of melanoma cells by a mitotoxin.
• An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.
• CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
• Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
• Dynamics of cell interactions and communications during melanoma development.
• Endothelial cells as targets for tumor therapy.
• Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.
• Learning the ABCs of Melanoma-Initiating Cells.
• Life isn't flat: taking cancer biology to the next dimension.
• Melanoma and the tumor microenvironment.
• Melanoma stem cells: the dark seed of melanoma.
• Old disease, new culprit: tumor stem cells in cancer.
• Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.
• Salmonella typhimurium as a novel RNA interference vector for cancer gene therapy.
• Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.
• Targeting the stromal fibroblasts: a novel approach to melanoma therapy.
• The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis.
• The many faces of Notch signaling in skin-derived cells.
• Unraveling the mysteries of IGF-1 signaling in melanoma.
• [1st successful immunization of pancreas and colorectal carcinoma patients with CO17-1A-vaccine]
• [Not Available.]
• [POSTOPERATIVE EFFECTS OF CESAREAN SECTION.]
• [Stability of Teschen, HCC, ND and vaccinia viruses against 5 disinfectants]